Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in J Endocrinol Invest Retrieve available abstracts of 143 articles: HTML format

Single Articles

August 2025
1. HAI Y, Ma Q, Huang A, Fang S, et al
   Bibliometrics in thyroid eye disease.
   J Endocrinol Invest. 2025 Aug 29. doi: 10.1007/s40618-025-02688.
   PubMed     Abstract available
   
   
   
2. CARRILLO JF, Carrillo LC, Serrano-Arevalo ML, Perez-Baez WB, et al
   Prognostic role of the BRAF V600E variant in the preoperative biopsy in differentiated thyroid cancer.
   J Endocrinol Invest. 2025 Aug 23. doi: 10.1007/s40618-025-02694.
   PubMed     Abstract available
   
   
   
3. GATTA E, Maltese V, Ugoccioni M, Silvestrini I, et al
   Could thyrotropin serum level characterize major depressive disorder phenotype? A systematic review and meta-analysis.
   J Endocrinol Invest. 2025 Aug 19. doi: 10.1007/s40618-025-02687.
   PubMed     Abstract available
   
   
   
4. MARINO PICCIOLA V, Zatelli MC, Sena LM
   Art, diet and thyroid disease: interpreting the goiter motif in the trivulzio tapestries.
   J Endocrinol Invest. 2025 Aug 12. doi: 10.1007/s40618-025-02685.
   PubMed    
   
   
   
5. PAN LH, Yeh CC, Yang SJ, Yang CC, et al
   A Prospective Study to Determine Trimester-Specific Thyroid Function Reference Intervals.
   J Endocrinol Invest. 2025 Aug 11. doi: 10.1007/s40618-025-02651.
   PubMed     Abstract available
   
   
   
6. LI X, Zhao H, Xiao Z
   Effects of sphingolipid metabolism related genes-SPTLC1, ORMDL3, SPHK1 and S1PR3 polymorphisms on susceptibility to hashimoto's thyroiditis.
   J Endocrinol Invest. 2025 Aug 9. doi: 10.1007/s40618-025-02666.
   PubMed     Abstract available
   
   
   
7. PALADINO ME, Riva MA
   The goitrous sponge-bearer in Francesco Bianchi Ferrari's Pala delle Tre Croci (c. 1495).
   J Endocrinol Invest. 2025 Aug 7. doi: 10.1007/s40618-025-02681.
   PubMed    
   
   
   
8. BARTALENA L, Gallo D, Kahaly GJ, Piantanida E, et al
   Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?
   J Endocrinol Invest. 2025 Aug 6. doi: 10.1007/s40618-025-02653.
   PubMed     Abstract available
   
   
   
9. YANG W, Xu X, Xie R, Lin J, et al
   Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation.
   J Endocrinol Invest. 2025;48:1781-1795.
   PubMed     Abstract available
   
   
   
10. MARTIN A, Fernandez MC, Miraglia S, Venara M, et al
    Brachyury and IGF1R: potential opposing roles in pediatric thyroid nodular pathology.
    J Endocrinol Invest. 2025 Aug 1. doi: 10.1007/s40618-025-02667.
    PubMed     Abstract available
    
    
    July 2025
11. HONKANEN J, Molnar K, Karhumaa T, Kakko S, et al
    Patients undergoing thyroid surgery suffer preoperatively from poor quality of life.
    J Endocrinol Invest. 2025 Jul 29. doi: 10.1007/s40618-025-02661.
    PubMed     Abstract available
    
    
    
12. CASIRAGHI A, Cattoni A, Persani L
    Update on diagnostic and therapeutic challenges of central hypothyroidism among childhood cancer survivors.
    J Endocrinol Invest. 2025 Jul 28. doi: 10.1007/s40618-025-02659.
    PubMed     Abstract available
    
    
    
13. WANG L, Cao J, Tian J, Zhang H, et al
    Characteristic volume, texture, and functional connectivity alterations in hypothalamic subunits of adult primary hypothyroidism: a multiparametric MRI analysis.
    J Endocrinol Invest. 2025 Jul 24. doi: 10.1007/s40618-025-02658.
    PubMed     Abstract available
    
    
    
14. GUGLIELMI R, Mian C, Novizio R, Paoletta A, et al
    Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy.
    J Endocrinol Invest. 2025 Jul 23. doi: 10.1007/s40618-025-02652.
    PubMed     Abstract available
    
    
    
15. MURA C, Fionda B, Rota CA, Pastore F, et al
    Role of Volumetric Modulated Arc radioTherapy (VMAT) in the adjuvant treatment of locally advanced differentiated thyroid cancer: single institution experience.
    J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02644.
    PubMed     Abstract available
    
    
    
16. LIU SY, Wang H, Wang T, Zhou LF, et al
    METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves' ophthalmopathy.
    J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02647.
    PubMed     Abstract available
    
    
    
17. LIU Q, Ma B, Song M, Sun H, et al
    Causes of death among patients with metastatic differentiated thyroid cancer.
    J Endocrinol Invest. 2025 Jul 7. doi: 10.1007/s40618-025-02643.
    PubMed     Abstract available
    
    
    
18. COMI S, Cosentino G, Sabini E, Ciampa DA, et al
    Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus.
    J Endocrinol Invest. 2025;48:1677-1682.
    PubMed     Abstract available
    
    
    June 2025
19. VANNUCCHI G, Amato C, Rotondi M, Persani L, et al
    Thyroid and female fertility: a survey on the clinical practice among endocrinologists belonging to the italian thyroid association.
    J Endocrinol Invest. 2025 Jun 30. doi: 10.1007/s40618-025-02613.
    PubMed    
    
    
    
20. TRIMARCHI F, Martino E, Bartalena L
    A mannequin resembling a young woman with Graves' disease.
    J Endocrinol Invest. 2025 Jun 16. doi: 10.1007/s40618-025-02628.
    PubMed    
    
    
    
21. MATUTINOVIC MS, Vladimirov S, Gojkovic T, Djuricic I, et al
    Analysis of non-cholesterol sterols and fatty acids in patients with graves' orbitopathy: insights into lipid metabolism in relation to the clinical phenotype of disease.
    J Endocrinol Invest. 2025;48:1333-1342.
    PubMed     Abstract available
    
    
    May 2025
22. YANG C, Wei R
    From pathology to symbol: the cultural reconstruction of Thyroid Eye Disease in ancient Chinese figures-case studies of Shu King Wang Jian and General Zhang Fei.
    J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02599.
    PubMed    
    
    
    
23. GRAFE W, Scheibe S, Schwarz J, Liebig L, et al
    The myth of iodine: A systematic review and meta-analysis on the relationship between iodine and thyroid nodule.
    J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02606.
    PubMed     Abstract available
    
    
    
24. PAPINI E, Basile M, Novizio R, Paoletta A, et al
    Cost analysis and resource allocation in the management of benign thyroid nodules: a comparison of surgery and thermal ablation techniques.
    J Endocrinol Invest. 2025 May 22. doi: 10.1007/s40618-025-02597.
    PubMed     Abstract available
    
    
    
25. XU Y, Xu Z, Chen Y, Yang J, et al
    Role of thyroid function in non-basal ganglia intracerebral hemorrhage prognosis.
    J Endocrinol Invest. 2025 May 15. doi: 10.1007/s40618-025-02603.
    PubMed     Abstract available
    
    
    
26. CHENG X, Xu S, Wu J, Gao W, et al
    Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity.
    J Endocrinol Invest. 2025 May 13. doi: 10.1007/s40618-025-02598.
    PubMed     Abstract available
    
    
    
27. MARINO PICCIOLA V, Ivaldi GP, Zamboni P
    The Fieschi conservatory of Genoa: art, medicine, and the representation of endemic goiter in 18 th-Century sculpture.
    J Endocrinol Invest. 2025 May 13. doi: 10.1007/s40618-025-02604.
    PubMed    
    
    
    
28. HAMMERSTAD SS, Lee HJ, Tomer Y, Stefan-Lifshitz M, et al
    Immune checkpoint inhibitors associated thyroiditis: mechanisms and clinical outcomes.
    J Endocrinol Invest. 2025 May 12. doi: 10.1007/s40618-025-02608.
    PubMed     Abstract available
    
    
    April 2025
29. LIN S, Ou X, Cai L, Huang W, et al
    Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis.
    J Endocrinol Invest. 2025 Apr 30. doi: 10.1007/s40618-025-02595.
    PubMed     Abstract available
    
    
    
30. ABDERREZAK K, Houyam A, Dana AA, Yamina A, et al
    Exposure profiles to Benzophenones and their impacts on thyroid hormones in pregnant women.
    J Endocrinol Invest. 2025 Apr 26. doi: 10.1007/s40618-025-02570.
    PubMed     Abstract available
    
    
    
31. TRIMARCHI F, Martino E, Bartalena L
    A model with thyroid swelling portrayed by Achille Funi in the painting "maternita".
    J Endocrinol Invest. 2025 Apr 23. doi: 10.1007/s40618-025-02588.
    PubMed    
    
    
    
32. ZHANG D, Zhao Q, Hou S, Qu C, et al
    Coronary morphological and functional features in subclinical hypothyroidism with ST-Elevation myocardial infarction.
    J Endocrinol Invest. 2025 Apr 3. doi: 10.1007/s40618-025-02576.
    PubMed     Abstract available
    
    
    
33. ACCORONA R, Cremasco A
    Emperor Leo I "the Thracian": a possible case of Graves' orbitopathy.
    J Endocrinol Invest. 2025;48:1057-1060.
    PubMed     Abstract available
    
    
    March 2025
34. SCAPPATICCIO L, Caruso P, Di Martino N, Ferrazzano P, et al
    Correction: Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    J Endocrinol Invest. 2025 Mar 25. doi: 10.1007/s40618-025-02573.
    PubMed    
    
    
    
35. COMI S, Cosentino G, Lanzolla G, Menconi F, et al
    Long-term outcome of Graves' orbitopathy following treatment with sirolimus.
    J Endocrinol Invest. 2025;48:607-618.
    PubMed     Abstract available
    
    
    
36. ZHANG H, Wu J, Hu H, Tang H, et al
    UBC9: a novel therapeutic target in papillary thyroid carcinoma.
    J Endocrinol Invest. 2025 Mar 1. doi: 10.1007/s40618-024-02523.
    PubMed     Abstract available
    
    
    February 2025
37. SATURNINO A, Pozzilli P, Trimarchi F
    Medical eyes on art: describing multinodular Goiter in Nicolini's Statue at the Aula Magna of University of Messina.
    J Endocrinol Invest. 2025 Feb 28. doi: 10.1007/s40618-025-02553.
    PubMed    
    
    
    
38. XIE Z, Liu J, Zhou J, Zhang X, et al
    MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p/SREBP1 axis.
    J Endocrinol Invest. 2025 Feb 13. doi: 10.1007/s40618-025-02550.
    PubMed     Abstract available
    
    
    
39. LIVADAS S, Angelopoulos N, Kollias A, Paparodis RD, et al
    Thyroxine overuse and clinical indices guiding successful treatment withdrawal.
    J Endocrinol Invest. 2025 Feb 3. doi: 10.1007/s40618-025-02543.
    PubMed     Abstract available
    
    
    January 2025
40. CHEN J, Chen Y, Huang R, Zhang P, et al
    Correction: Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-kappaB signaling.
    J Endocrinol Invest. 2025 Jan 28. doi: 10.1007/s40618-025-02538.
    PubMed    
    
    
    
41. RIVA MA
    Shepherd with goiter in the late-Renaissance Nativity scene of the Canonica di San Salvatore in Barzano.
    J Endocrinol Invest. 2025 Jan 27. doi: 10.1007/s40618-025-02539.
    PubMed    
    
    
    
42. NAPPI A, Miro C, Cicatiello AG, Sagliocchi S, et al
    The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target.
    J Endocrinol Invest. 2025 Jan 17. doi: 10.1007/s40618-024-02526.
    PubMed     Abstract available
    
    
    
43. CHEN J, Chen Y, Rong H, Zhang P, et al
    Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-kappaB signaling.
    J Endocrinol Invest. 2025 Jan 9. doi: 10.1007/s40618-025-02531.
    PubMed     Abstract available
    
    
    December 2024
44. TRIMBOLI P, Colombo A, Gamarra E, Ruinelli L, et al
    Performance of computer scientists in the assessment of thyroid nodules using TIRADS lexicons.
    J Endocrinol Invest. 2024 Dec 18. doi: 10.1007/s40618-024-02518.
    PubMed     Abstract available
    
    
    
45. DENG Y, Pan L, Xu Y, Duan Y, et al
    Aggressive variants of papillary thyroid carcinoma: characteristics, influencing factors, and effectiveness of radioiodine therapy.
    J Endocrinol Invest. 2024 Dec 9. doi: 10.1007/s40618-024-02507.
    PubMed     Abstract available
    
    
    
46. ZHANG L, He M, Liu Y, Wang B, et al
    The immune mechanism of the mTOR/ACC1/CPT1A fatty acid oxidation signaling pathway in Hashimoto's thyroiditis.
    J Endocrinol Invest. 2024 Dec 6. doi: 10.1007/s40618-024-02501.
    PubMed     Abstract available
    
    
    
47. PITICCHIO T, Wolde Sellasie S, D'Arrigo F, Galeano F, et al
    Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem.
    J Endocrinol Invest. 2024 Dec 4. doi: 10.1007/s40618-024-02510.
    PubMed     Abstract available
    
    
    November 2024
48. DING H, Qin J, Li Y, Dai L, et al
    Lactoferrin alleviates oxidative stress and endoplasmic reticulum stress induced by autoimmune thyroiditis by modulating the mTOR pathway in the thyroid.
    J Endocrinol Invest. 2024 Nov 22. doi: 10.1007/s40618-024-02505.
    PubMed     Abstract available
    
    
    
49. PAJA M, Del Cura JL, Zabala R, Korta I, et al
    A simplified four-tier classification for thyroid core needle biopsy.
    J Endocrinol Invest. 2024 Nov 22. doi: 10.1007/s40618-024-02508.
    PubMed     Abstract available
    
    
    
50. SU Y, Mei L, Wu Y, Li C, et al
    Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway.
    J Endocrinol Invest. 2024 Nov 2. doi: 10.1007/s40618-024-02481.
    PubMed     Abstract available
    
    
    
51. CARUSO I, Di Gioia L, Di Molfetta S, Caporusso M, et al
    The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.
    J Endocrinol Invest. 2024;47:2671-2678.
    PubMed     Abstract available
    
    
    October 2024
52. SONG ZM, Wang YD, Chai F, Zhang J, et al
    Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERalpha/KRT19 signaling axis.
    J Endocrinol Invest. 2024 Oct 25. doi: 10.1007/s40618-024-02473.
    PubMed     Abstract available
    
    
    
53. PITICCHIO T, Luongo C, Trimboli P, Salvatore D, et al
    Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism.
    J Endocrinol Invest. 2024 Oct 21. doi: 10.1007/s40618-024-02480.
    PubMed     Abstract available
    
    
    
54. ZHANG C, Liu A, Teng W, Yang W, et al
    Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the MARCH study.
    J Endocrinol Invest. 2024 Oct 14. doi: 10.1007/s40618-024-02463.
    PubMed     Abstract available
    
    
    
55. NERLICH AG, Perciaccante A, Bianucci R
    Severe goitre and hypothyroidism in the Austrian Biedermeier style portrait of Eleonore Feldmuller (1775-1837).
    J Endocrinol Invest. 2024 Oct 13. doi: 10.1007/s40618-024-02477.
    PubMed    
    
    
    
56. MENEGHINI V, Tebar WR, Santos IS, Janovsky CCPS, et al
    Thyroid peroxidase antibodies were associated with prevalent carotid intima-media thickness in middle-age and older adults: the ELSA-Brasil cohort.
    J Endocrinol Invest. 2024 Oct 9. doi: 10.1007/s40618-024-02475.
    PubMed     Abstract available
    
    
    
57. CAMPI I, Fugazzola L
    Utility of ultra-portable ultrasound devices for the risk-stratification of thyroid dysfunctions in an emergency setting.
    J Endocrinol Invest. 2024 Oct 7. doi: 10.1007/s40618-024-02437.
    PubMed     Abstract available
    
    
    
58. WU R, Li N, Wang X, Wang S, et al
    Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R alpha subunit gene.
    J Endocrinol Invest. 2024;47:2507-2519.
    PubMed     Abstract available
    
    
    
59. WANG Y, Li J, Gao S, Dang D, et al
    The role of TMEM163 protein in thyroid microcarcinoma: expression pattern and clinical implications.
    J Endocrinol Invest. 2024 Oct 1. doi: 10.1007/s40618-024-02434.
    PubMed     Abstract available
    
    
    September 2024
60. VERRIENTI A, Pecce V, Grani G, Del Gatto V, et al
    Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma.
    J Endocrinol Invest. 2024 Sep 19. doi: 10.1007/s40618-024-02467.
    PubMed     Abstract available
    
    
    
61. LE MOLI R, Naselli A, Giudice FL, Costanzo G, et al
    Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.
    J Endocrinol Invest. 2024;47:2177-2184.
    PubMed     Abstract available
    
    
    August 2024
62. PELEWICZ K, Miskiewicz P
    Glucocorticoid-induced adrenal insufficiency after therapy with intravenous methylprednisolone in patients with moderate-to-severe and active Graves' orbitopathy: assessment with a low-dose corticotropin test.
    J Endocrinol Invest. 2024;47:1987-1994.
    PubMed     Abstract available
    
    
    
63. ZHAO YX, Wang O, Song A, Wang LJ, et al
    The risk of concurrent malignancies in patients with multiple endocrine neoplasia type 1: insights into clinical characteristics of those with multiple endocrine neoplasia type 1.
    J Endocrinol Invest. 2024;47:1931-1939.
    PubMed     Abstract available
    
    
    July 2024
64. MA J, Li Z, Xu J, Lai J, et al
    PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination.
    J Endocrinol Invest. 2024 Jul 16. doi: 10.1007/s40618-024-02385.
    PubMed     Abstract available
    
    
    
65. MARINO PICCIOLA V, Zamboni P, Zavagli G
    The paintings as figurative evidence of endemic goiter and cretinism in South West Piedmont in the fifteenth and sixteenth centuries.
    J Endocrinol Invest. 2024 Jul 2. doi: 10.1007/s40618-024-02424.
    PubMed    
    
    
    
66. ALBERTELLI M, Rossi G, Nazzari E, Genova C, et al
    Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
    J Endocrinol Invest. 2024;47:1805-1814.
    PubMed     Abstract available
    
    
    
67. SOUBRY E, David K, Swillen A, Vergaelen E, et al
    Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study.
    J Endocrinol Invest. 2024;47:1827-1836.
    PubMed     Abstract available
    
    
    
68. COMI S, Lanzolla G, Cosentino G, Maglionico MN, et al
    IgG4 serum levels in Graves' orbitopathy.
    J Endocrinol Invest. 2024;47:1711-1717.
    PubMed     Abstract available
    
    
    June 2024
69. ZAVAGLI G, Marino Picciola V, Zamboni P
    Sculptures with goiter in the Ossuccio Sacred Mount: when pathognomonic signs have a specific moral significance.
    J Endocrinol Invest. 2024 Jun 26. doi: 10.1007/s40618-024-02423.
    PubMed    
    
    
    
70. ZHOU YY, Zhao SY, Huang FJ, Zhang LJ, et al
    JPT2 in subclinical hypothyroidism-related miscarriage as a transcription co-factor: involvement of LEPR/STAT3 activation.
    J Endocrinol Invest. 2024 Jun 22. doi: 10.1007/s40618-024-02343.
    PubMed     Abstract available
    
    
    
71. COPERCHINI F, Greco A, Petrosino E, Croce L, et al
    Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.
    J Endocrinol Invest. 2024 Jun 20. doi: 10.1007/s40618-024-02410.
    PubMed     Abstract available
    
    
    
72. GALOFRE JC, Diez JJ, Attanasio R, Nagy EV, et al
    Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.
    J Endocrinol Invest. 2024 Jun 15. doi: 10.1007/s40618-024-02409.
    PubMed     Abstract available
    
    
    
73. BENELLI E, Marradi M, Sciarroni E, Di Cosmo C, et al
    Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience.
    J Endocrinol Invest. 2024 Jun 8. doi: 10.1007/s40618-024-02404.
    PubMed     Abstract available
    
    
    
74. BIANUCCI R, Perciaccante A, Nerlich AG
    The laywoman church builder Lucrezia Agliarti Vertova (ca 1484-March 24th 1557) had endemic goitre.
    J Endocrinol Invest. 2024;47:1583-1584.
    PubMed    
    
    
    May 2024
75. XIAO R, Wang Q, Ni C, Pan W, et al
    Interplay of metabolic dysfunction-associated fatty liver disease and papillary thyroid carcinoma: insights from a Chinese cohort.
    J Endocrinol Invest. 2024 May 24. doi: 10.1007/s40618-024-02391.
    PubMed     Abstract available
    
    
    
76. BOROWCZYK M, Kaczmarek-Rys M, Hryhorowicz S, Sypniewski M, et al
    Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.
    J Endocrinol Invest. 2024 May 16. doi: 10.1007/s40618-024-02389.
    PubMed     Abstract available
    
    
    
77. ZENG C, Zhang Y, Lin C, Liang W, et al
    TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression.
    J Endocrinol Invest. 2024 May 16. doi: 10.1007/s40618-024-02392.
    PubMed     Abstract available
    
    
    
78. LU J, Liu X, Cen A, Hong Y, et al
    HYPOXIA induces lncRNA HOTAIR for recruiting RELA in papillary thyroid cancer cells to upregulate miR-181a and promote angiogenesis.
    J Endocrinol Invest. 2024 May 15. doi: 10.1007/s40618-024-02388.
    PubMed     Abstract available
    
    
    
79. OTERI V, Piane S, Cocci E
    The use of telecytology for the evaluation of thyroid nodules fine-needle aspiration biopsy specimens: a systematic review.
    J Endocrinol Invest. 2024 May 4. doi: 10.1007/s40618-024-02378.
    PubMed     Abstract available
    
    
    
80. HEYDARZADEH S, Moshtaghie AA, Daneshpour M, Hedayati M, et al
    Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
    J Endocrinol Invest. 2024 May 2. doi: 10.1007/s40618-024-02377.
    PubMed     Abstract available
    
    
    April 2024
81. STRAMAZZO I, Mangino G, Capriello S, Romeo G, et al
    CD20 + T lymphocytes in isolated Hashimoto's thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study.
    J Endocrinol Invest. 2024 Apr 20. doi: 10.1007/s40618-024-02370.
    PubMed     Abstract available
    
    
    
82. SCHUBERT L, Mbekwe-Yepnang AM, Wassermann J, Braik-Djellas Y, et al
    Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status.
    J Endocrinol Invest. 2024 Apr 5. doi: 10.1007/s40618-024-02352.
    PubMed     Abstract available
    
    
    March 2024
83. SCAPPATICCIO L, Caruso P, Di Martino N, Ferrazzano P, et al
    Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    J Endocrinol Invest. 2024 Mar 30. doi: 10.1007/s40618-024-02355.
    PubMed     Abstract available
    
    
    
84. OZER Y, Anik A, Sayili U, Tercan U, et al
    High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National screening program: thyroxine dose may guide the prediction of transients.
    J Endocrinol Invest. 2024 Mar 28. doi: 10.1007/s40618-024-02348.
    PubMed     Abstract available
    
    
    
85. JANSEN HI, Heuveling van Beek C, Bisschop PH, Heijboer AC, et al
    The need for the GREAT+ score to predict relapse in Graves' disease: a questionnaire among patients and internal medicine specialists.
    J Endocrinol Invest. 2024 Mar 25. doi: 10.1007/s40618-024-02358.
    PubMed     Abstract available
    
    
    
86. COPERCHINI F, Greco A, Rotondi M
    Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
    J Endocrinol Invest. 2024 Mar 24. doi: 10.1007/s40618-024-02339.
    PubMed     Abstract available
    
    
    
87. MENOTTI S, Mura C, Raia S, Bergianti L, et al
    Overt hypothyroidism in pregnancy and language development in offspring: is there an association?
    J Endocrinol Invest. 2024 Mar 18. doi: 10.1007/s40618-024-02317.
    PubMed     Abstract available
    
    
    
88. WANG C, Wang Z, Fu L, Du J, et al
    CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.
    J Endocrinol Invest. 2024 Mar 14. doi: 10.1007/s40618-023-02241.
    PubMed     Abstract available
    
    
    
89. D'ANIELLO F, Amodeo ME, Grossi A, Ubertini G, et al
    Thyroiditis and COVID-19: focus on pediatric age. A narrative review.
    J Endocrinol Invest. 2024 Mar 8. doi: 10.1007/s40618-024-02331.
    PubMed     Abstract available
    
    
    
90. SPARANO C, Puccioni M, Adornato V, Zago E, et al
    Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.
    J Endocrinol Invest. 2024;47:633-643.
    PubMed     Abstract available
    
    
    February 2024
91. ZHANG GQ, Xi C, Ju NT, Shen CT, et al
    Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
    J Endocrinol Invest. 2024 Feb 22. doi: 10.1007/s40618-023-02294.
    PubMed     Abstract available
    
    
    
92. BABAYID Y, Gokcay Canpolat A, Elhan AH, Ceyhan K, et al
    Should there be a paradigm shift for the evaluation of isthmic thyroid nodules?
    J Endocrinol Invest. 2024 Feb 16. doi: 10.1007/s40618-024-02313.
    PubMed     Abstract available
    
    
    
93. LIU L, Cai S, Chen A, Dong Y, et al
    Long-term prognostic value of thyroid hormones in left ventricular noncompaction.
    J Endocrinol Invest. 2024 Feb 15. doi: 10.1007/s40618-024-02311.
    PubMed     Abstract available
    
    
    
94. EVRANOS BO, Ince N, Atas H, Polat SB, et al
    Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection.
    J Endocrinol Invest. 2024 Feb 14. doi: 10.1007/s40618-024-02301.
    PubMed     Abstract available
    
    
    
95. CENSI S, Carducci S, Zoppini G, Toffalini A, et al
    Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia.
    J Endocrinol Invest. 2024;47:357-365.
    PubMed     Abstract available
    
    
    January 2024
96. HE C, Li Y, Gan L, Lin Y, et al
    Notch signaling regulates Th17 cells differentiation through PI3K/AKT/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis.
    J Endocrinol Invest. 2024 Jan 29. doi: 10.1007/s40618-023-02293.
    PubMed     Abstract available
    
    
    
97. KENARLI K, Bahcecioglu AB, Aksu OB, Gullu S, et al
    Are sonographic characteristics of Hashimoto's thyroiditis related with immunologic parameters? A cross-sectional study.
    J Endocrinol Invest. 2024 Jan 21. doi: 10.1007/s40618-023-02286.
    PubMed     Abstract available
    
    
    
98. LOSA M, Albano L, Barzaghi LR, Bailo M, et al
    Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas.
    J Endocrinol Invest. 2024 Jan 20. doi: 10.1007/s40618-023-02291.
    PubMed     Abstract available
    
    
    
99. TAGGI M, Capponi C, Bertani N, Saturno G, et al
    Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum.
    J Endocrinol Invest. 2024 Jan 8. doi: 10.1007/s40618-023-02269.
    PubMed     Abstract available
    
    
    
100. COSENTINO G, Comi S, Maglionico MN, Marino M, et al
     A case of carotid cavernous fistula mimicking Graves' orbitopathy.
     J Endocrinol Invest. 2024;47:255-256.
     PubMed    
     
     
     December 2023
101. LU DN, Zhang WC, Lin YZ, Jiang HY, et al
     Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
     J Endocrinol Invest. 2023 Dec 26. doi: 10.1007/s40618-023-02262.
     PubMed     Abstract available
     
     
     
102. GONG Z, Xue L, Vlantis AC, van Hasselt CA, et al
     Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
     J Endocrinol Invest. 2023 Dec 7. doi: 10.1007/s40618-023-02248.
     PubMed     Abstract available
     
     
     November 2023
103. PRETE A, Pieroni E, Marrama E, Bruschini L, et al
     Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments.
     J Endocrinol Invest. 2023 Nov 30. doi: 10.1007/s40618-023-02234.
     PubMed     Abstract available
     
     
     
104. FELDT-RASMUSSEN U, Effraimidis G, Bliddal S, Klose M, et al
     Risks of suboptimal and excessive thyroid hormone replacement across ages.
     J Endocrinol Invest. 2023 Nov 28. doi: 10.1007/s40618-023-02229.
     PubMed     Abstract available
     
     
     
105. BEDULEVA L, Sidorov A, Fomina K, Terentiev A, et al
     Experimental rat models for Hashimoto's thyroiditis.
     J Endocrinol Invest. 2023 Nov 27. doi: 10.1007/s40618-023-02240.
     PubMed     Abstract available
     
     
     October 2023
106. LEI C, Qu M, Sun H, Huang J, et al
     Facial expression of patients with Graves' orbitopathy.
     J Endocrinol Invest. 2023;46:2055-2066.
     PubMed     Abstract available
     
     
     
107. CAO J, Qi X, Wang N, Chen Y, et al
     Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
     J Endocrinol Invest. 2023;46:2005-2016.
     PubMed     Abstract available
     
     
     September 2023
108. CAPPELLANI D, Bartalena L, Bogazzi F
     Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis.
     J Endocrinol Invest. 2023 Sep 20. doi: 10.1007/s40618-023-02168.
     PubMed     Abstract available
     
     
     
109. CROCE L, Ruggeri RM, Cappelli C, Virili C, et al
     Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis.
     J Endocrinol Invest. 2023 Sep 13. doi: 10.1007/s40618-023-02191.
     PubMed     Abstract available
     
     
     August 2023
110. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
     Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
     J Endocrinol Invest. 2023 Aug 10. doi: 10.1007/s40618-023-02172.
     PubMed    
     
     
     
111. ZHANG H, Xie H, Li L
     Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
     J Endocrinol Invest. 2023 Aug 6. doi: 10.1007/s40618-023-02159.
     PubMed     Abstract available
     
     
     
112. LANZOLLA G, Di Matteo L, Comi S, Cosentino G, et al
     Absence of a relationship between vitamin D and Graves' orbitopathy.
     J Endocrinol Invest. 2023;46:1717-1721.
     PubMed    
     
     
     July 2023
113. JIANG C, Xu F, Yi D, Jiang B, et al
     Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1.
     J Endocrinol Invest. 2023 Jul 21. doi: 10.1007/s40618-023-02132.
     PubMed     Abstract available
     
     
     
114. WUSIMAN D, Guo L, Li L, Zhang X, et al
     Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study.
     J Endocrinol Invest. 2023 Jul 18. doi: 10.1007/s40618-023-02126.
     PubMed     Abstract available
     
     
     
115. PELEWICZ-SOWA M, Miskiewicz P
     Dysthyroid optic neuropathy: emerging treatment strategies.
     J Endocrinol Invest. 2023;46:1305-1316.
     PubMed     Abstract available
     
     
     June 2023
116. MA Q, Chen Z, Fang Y, Wei X, et al
     Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
     J Endocrinol Invest. 2023 Jun 9. doi: 10.1007/s40618-023-02129.
     PubMed     Abstract available
     
     
     
117. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
     Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
     J Endocrinol Invest. 2023 Jun 7. doi: 10.1007/s40618-023-02115.
     PubMed     Abstract available
     
     
     May 2023
118. ASHRAFIAN H
     Goiter in the paintings by Rogier van der Weyden (1399-1464).
     J Endocrinol Invest. 2023 May 12. doi: 10.1007/s40618-023-02108.
     PubMed    
     
     
     
119. ASHRAFIAN H
     Goiter, thyroid facial involvement and eye disease in the paintings of Jan Gossaert (c. 1478-1532).
     J Endocrinol Invest. 2023 May 6. doi: 10.1007/s40618-023-02104.
     PubMed    
     
     
     
120. JIANG B, Wang C, Qu C, Jiang C, et al
     Primary human thyrocytes maintained the function of thyroid hormone production and secretion in vitro.
     J Endocrinol Invest. 2023 May 3. doi: 10.1007/s40618-023-02103.
     PubMed     Abstract available
     
     
     
121. BIANUCCI R, Galassi FM, Donell ST, Nerlich AG, et al
     Goitre in a Fayum mummy portrait from Roman Egypt (120-140 CE).
     J Endocrinol Invest. 2023;46:1041-1042.
     PubMed    
     
     
     April 2023
122. BERLINSKA A, Swiatkowska-Stodulska R
     Simple nontoxic goiter in the portrayal of Saints: a magnificent representation in one piece of art.
     J Endocrinol Invest. 2023 Apr 28. doi: 10.1007/s40618-023-02097.
     PubMed    
     
     
     
123. DORIZZI RM, Spiazzi G, Rolli N, Maltoni P, et al
     Trimester-specific reference intervals for thyroid function parameters in pregnant Caucasian women using Roche platforms: a prospective study.
     J Endocrinol Invest. 2023 Apr 24. doi: 10.1007/s40618-023-02098.
     PubMed     Abstract available
     
     
     
124. LORUSSO L, Minaldi E, Esposito G, Piaggi P, et al
     Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.
     J Endocrinol Invest. 2023 Apr 21. doi: 10.1007/s40618-023-02076.
     PubMed     Abstract available
     
     
     
125. RUGGERI RM, Spagnolo CC, Alibrandi A, Silvestris N, et al
     Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.
     J Endocrinol Invest. 2023 Apr 20. doi: 10.1007/s40618-023-02096.
     PubMed     Abstract available
     
     
     
126. GRANI G, Lamartina L, Montesano T, Maranghi M, et al
     Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach.
     J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02087.
     PubMed     Abstract available
     
     
     
127. PERONA M, Ibanez IL, Thomasz L, Villaverde MS, et al
     Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
     J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02092.
     PubMed     Abstract available
     
     
     
128. CALCATERRA V, Gazzarri A, De Silvestri A, Madia C, et al
     Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome.
     J Endocrinol Invest. 2023 Apr 11. doi: 10.1007/s40618-023-02086.
     PubMed     Abstract available
     
     
     
129. PINTO S, Croce L, Carlier L, Cosson E, et al
     Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship.
     J Endocrinol Invest. 2023 Apr 7. doi: 10.1007/s40618-023-02079.
     PubMed     Abstract available
     
     
     
130. SARIC MATUTINOVIC M, Kahaly GJ, Zarkovic M, Ciric J, et al
     The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.
     J Endocrinol Invest. 2023 Apr 5. doi: 10.1007/s40618-023-02085.
     PubMed     Abstract available
     
     
     
131. SIGMAN B, Linder DF, Waller JL, Bollag WB, et al
     Hashimoto's thyroiditis and renal transplant rejection.
     J Endocrinol Invest. 2023 Apr 4. doi: 10.1007/s40618-023-02065.
     PubMed     Abstract available
     
     
     
132. COSENTINO G, Comi S, Coco B, Marino M, et al
     Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves' orbitopathy.
     J Endocrinol Invest. 2023;46:849-850.
     PubMed    
     
     
     
133. BETTERLE C, Furmaniak J, Sabbadin C, Scaroni C, et al
     Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
     J Endocrinol Invest. 2023;46:643-665.
     PubMed     Abstract available
     
     
     
134. MODICA R, Benevento E, Colao A
     Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
     J Endocrinol Invest. 2023;46:667-677.
     PubMed     Abstract available
     
     
     
135. LI YY, Li SJ, Liu MC, Chen Z, et al
     B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
     J Endocrinol Invest. 2023 Apr 1. doi: 10.1007/s40618-023-02072.
     PubMed     Abstract available
     
     
     March 2023
136. PATTI L, Gay S, Musso L, Maltese C, et al
     Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
     J Endocrinol Invest. 2023 Mar 28. doi: 10.1007/s40618-023-02070.
     PubMed     Abstract available
     
     
     
137. BAGALA V, Sala A, Trevisan C, Okoye C, et al
     Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study.
     J Endocrinol Invest. 2023 Mar 27:1-9. doi: 10.1007/s40618-023-02048.
     PubMed     Abstract available
     
     
     
138. PECCE V, Sponziello M, Verrienti A, Grani G, et al
     The role of miR-139-5p in radioiodine-resistant thyroid cancer.
     J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02059.
     PubMed     Abstract available
     
     
     
139. MONTI E, Gay S, Dono M, Giusti M, et al
     PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.
     J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02063.
     PubMed    
     
     
     
140. FELICETTI F, Gatti F, Faraci D, Rosso D, et al
     Impact of allogeneic stem cell transplantation on thyroid function.
     J Endocrinol Invest. 2023 Mar 8. doi: 10.1007/s40618-023-02039.
     PubMed     Abstract available
     
     
     February 2023
141. BRANCATELLA A, Torregrossa L, Viola N, Sgro D, et al
     In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features.
     J Endocrinol Invest. 2023 Feb 25. doi: 10.1007/s40618-023-02044.
     PubMed     Abstract available
     
     
     
142. DI SESSA A, Cembalo Sambiase Sanseverino N, De Simone RF, Marrapodi MM, et al
     Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity.
     J Endocrinol Invest. 2023 Feb 24. doi: 10.1007/s40618-023-02041.
     PubMed     Abstract available
     
     
     March 2021
143. TRIMARCHI F, Martino E, Bartalena L
     The Virgin Mary with a small goiter breastfeeding the Child.
     J Endocrinol Invest. 2021;44:641-642.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.